Dr Vijay Mallya (Photo courtesy: www.newsmobile.in)
Sanofi India Limited (SIL) has announced that its Chairman of the Board of Directors, Dr Vijay Mallya has conveyed his decision to not seek re-election as a Director at the ensuing Annual General Meeting (AGM).
He became a Director of the Company (then called Hoechst Pharmaceuticals Limited) in December 1973 and has been Chairman of the Board since December 1983.
Dr Mallya, in his message to the SIL Board of Directors, stated, "I have been privileged to preside over the Board of this Company, which started as Hoechst Pharmaceuticals Ltd. and to have participated in its phenomenal growth and prosperity over such an extraordinarily long period of time."
He further added, "Today, Sanofi India Limited is not only financially strong but with an impeccable track record. It is gratifying to me that the Company continues to serve needy patients in India with world-class medication whilst ensuring consistent returns to all stakeholders."
Dr Shailesh Ayyangar, managing director - SIL stated, "The Board of Directors while accepting Dr Mallya's decision, placed on record its deep appreciation of his exceptional service and leadership, firstly as a Director and subsequently as Chairman of the Board for over four decades."